Sign Up to like & get recommendations! 0
Published in 2017 at "Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery"
DOI: 10.1097/imi.0000000000000340
Abstract: Pulmonary toxicity is a devastating complication of bleomycin chemotherapy. This insult is likely exacerbated by the free radical injury induced by high inspired oxygen content, which is required to support these patients. Traditional treatment consists… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "ASAIO Journal"
DOI: 10.1097/mat.0000000000001698
Abstract: Bleeding and thromboembolic events are common during veno-venous extracorporeal membrane oxygenation (vvECMO). It is unknown whether these complications are driven by the ECMO system itself, multiorgan-failure, or both. The aim of this study was to… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "ASAIO Journal"
DOI: 10.1097/mat.0000000000001849
Abstract: The Extracorporeal Life Support Organisation (ELSO) recommends initiating veno-venous extracorporeal membrane oxygenation (ECMO) with sweep gas flow rate (V˙sweep) of 2 L/min and extracorporeal circuit blood flow ( Q˙ec) of 2 L/min. We used an in-silico model… read more here.
Sign Up to like & get recommendations! 1
Published in 2023 at "ASAIO Journal"
DOI: 10.1097/mat.0000000000001929
Abstract: Veno-venous extracorporeal membrane oxygenation (VV ECMO) is used as a treatment modality in those who fail to respond to conventional care. Hypoxia and medications used in the intensive care unit may increase risk for atrial… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "ERJ Open Research"
DOI: 10.1183/23120541.00383-2022
Abstract: Background Veno-venous extracorporeal membrane oxygenation (VV-ECMO) is essential life support in patients with severe acute hypoxaemic respiratory failure. However, biopsies should be considered for some patients with unknown aetiology. This study aims to evaluate the… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "ERJ Open Research"
DOI: 10.1183/23120541.00463-2020
Abstract: Background The use of veno-venous extracorporeal membrane oxygenation (VV-ECMO) in severe hypoxaemic respiratory failure from coronavirus disease 2019 (COVID-19) has been described, but reported utilisation and outcomes are variable, and detailed information on patient characteristics… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "BMC Infectious Diseases"
DOI: 10.1186/s12879-020-05518-1
Abstract: Background Pulmonary hemorrhage is an important complication of leptospirosis. Once acute respiratory distress syndrome (ARDS) occurs as a secondary condition, treatment is extremely difficult and the mortality rate is very high. Case presentation The patient… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14050974
Abstract: Background: Adjusting drug therapy under veno-venous extracorporeal membrane oxygenation (VV ECMO) is challenging. Although impaired pharmacokinetics (PK) under VV ECMO have been reported for sedative drugs and antibiotics, data about amiodarone are lacking. We evaluated… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Anaesthesiology intensive therapy"
DOI: 10.5114/ait.2019.90235
Abstract: BACKGROUND Veno-venous extracorporeal membrane oxygenation (VV-ECMO) is a well-established therapeutic option in respiratory failure refractory to mechanical ventilation. Due to the growing popularity of VV-ECMO, new methods to improve patient outcome are desired. This study… read more here.